Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Unmet care needs of the oldest old with late-life depression: A comparison of patient, caring relative and general practitioner perceptions - Results of the AgeMooDe study.

Stein J, Pabst A, Weyerer S, Werle J, Maier W, Miebach L, Scherer M, Stark A, Kaduszkiewicz H, Wiese B, Moor L, Bock JO, König HH, Riedel-Heller SG.

J Affect Disord. 2016 Jul 5;205:182-189. doi: 10.1016/j.jad.2016.07.001. [Epub ahead of print]

PMID:
27449550
2.

Excess health care costs of late-life depression - Results of the AgeMooDe study.

Bock JO, Brettschneider C, Weyerer S, Werle J, Wagner M, Maier W, Scherer M, Kaduszkiewicz H, Wiese B, Moor L, Stein J, Riedel-Heller SG, König HH.

J Affect Disord. 2016 Jul 15;199:139-47. doi: 10.1016/j.jad.2016.04.008. Epub 2016 Apr 12.

PMID:
27104802
3.

An overview on the development of new potentially active camptothecin analogs against cancer.

Chazin Ede L, Reis Rda R, Junior WT, Moor LF, Vasconcelos TR.

Mini Rev Med Chem. 2014;14(12):953-62. Review.

PMID:
25355593
4.

Determinants of weight gain in the action to control cardiovascular risk in diabetes trial.

Fonseca V, McDuffie R, Calles J, Cohen RM, Feeney P, Feinglos M, Gerstein HC, Ismail-Beigi F, Morgan TM, Pop-Busui R, Riddle MC; ACCORD Study Group.

Diabetes Care. 2013 Aug;36(8):2162-8. doi: 10.2337/dc12-1391. Epub 2013 Feb 14.

5.

Long-term effects of intensive glucose lowering on cardiovascular outcomes.

ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH Jr, Byington RP, Rosenberg YD, Friedewald WT.

N Engl J Med. 2011 Mar 3;364(9):818-28. doi: 10.1056/NEJMoa1006524.

6.

Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.

Desplat V, Moreau S, Belisle-Fabre S, Thiolat D, Uranga J, Lucas R, de Moor L, Massip S, Jarry C, Mossalayi DM, Sonnet P, Déléris G, Guillon J.

J Enzyme Inhib Med Chem. 2011 Oct;26(5):657-67. doi: 10.3109/14756366.2010.548326. Epub 2011 Jan 21.

PMID:
21250818
7.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD trial group.

Lancet. 2010 Aug 7;376(9739):419-30. doi: 10.1016/S0140-6736(10)60576-4. Epub 2010 Jun 30. Erratum in: Lancet. 2010 Oct 30;376(9751):1466.

8.

Effects of medical therapies on retinopathy progression in type 2 diabetes.

ACCORD Study Group; ACCORD Eye Study Group, Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ.

N Engl J Med. 2010 Jul 15;363(3):233-44. doi: 10.1056/NEJMoa1001288. Epub 2010 Jun 29. Erratum in: N Engl J Med. 2011 Jan 13;364(2):190. N Engl J Med. 2012 Dec 20;367(25):2458.

9.

Effects of combination lipid therapy in type 2 diabetes mellitus.

ACCORD Study Group, Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP.

N Engl J Med. 2010 Apr 29;362(17):1563-74. doi: 10.1056/NEJMoa1001282. Epub 2010 Mar 14. Erratum in: N Engl J Med. 2010 May 6;362(18):1748.

10.

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F.

N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.

11.

Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials.

Mount DL, Feeney P, Fabricatore AN, Coday M, Bahnson J, Byington R, Phelan S, Wilmoth S, Knowler WC, Hramiak I, Osei K, Sweeney ME, Espeland MA; Look AHEAD and ACCORD Research Groups.

Clin Trials. 2009 Oct;6(5):416-29. doi: 10.1177/1740774509344440. Epub 2009 Sep 8.

12.
13.

A cohort study of haemoglobin and zinc protoporphyrin levels in term Zambian infants: effects of iron stores at birth, complementary food and placental malaria.

van Rheenen PF, de Moor LT, Eschbach S, Brabin BJ.

Eur J Clin Nutr. 2008 Dec;62(12):1379-87. Epub 2007 Aug 1.

PMID:
17671442
14.

Delayed cord clamping and haemoglobin levels in infancy: a randomised controlled trial in term babies.

van Rheenen P, de Moor L, Eschbach S, de Grooth H, Brabin B.

Trop Med Int Health. 2007 May;12(5):603-16.

16.

[Children of migrants of the second generation].

Moor L.

Rev Infirm. 1984 Jun;34(12):28-30. French. No abstract available.

PMID:
6566415
17.

[French versions of depression rating scales].

Moor L, Mack C.

Neuropsychiatr Enfance Adolesc. 1982 Oct-Nov;30(10-11):623-52. French. No abstract available.

PMID:
7155324
18.

[Indications for and prescription of psychotropic drugs in child and adolescent psychiatry].

Moor L.

Neuropsychiatr Enfance Adolesc. 1981 Oct;29(10):537-42. French. No abstract available.

PMID:
7301061
19.

[Evaluation scales. II. Infantile autism].

Moor L.

Neuropsychiatr Enfance Adolesc. 1981 Jul-Aug;29(7):379-80. French. No abstract available.

PMID:
7290371
20.

[Influence of television on child and adolescent psyche (author's transl)].

Moor L.

Neuropsychiatr Enfance Adolesc. 1981 Mar;29(3):151-6. French. No abstract available.

PMID:
7207733
Items per page

Supplemental Content

Loading ...
Write to the Help Desk